InvestorsHub Logo
Followers 58
Posts 10213
Boards Moderated 1
Alias Born 09/21/2016

Re: XenaLives post# 147187

Wednesday, 04/11/2018 5:44:23 PM

Wednesday, April 11, 2018 5:44:23 PM

Post# of 465265
https://www.bloomberg.com/news/articles/2018-02-14/biogen-drops-after-alzheimer-s-drug-trial-change-raises-concerns

Cannot keep a straight face when you read this pr piece...
comments like...,"Not a good sign" and "considered a very risky pipeline candidate"


I can just imagine the yelling that went on before this release...for example..."I don't know...tell them it is statistical noise abatement".

IMO, they bought some time to splain a very expensive trial that no one expects to produce positive or usable results. We'll see, hey, "what could go wrong"?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News